(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1317577 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TP53BP1 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression ISO RGD:1317578 6480464 1, 2-Dimethylhydrazine results in increased expression of TRP53BP1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1317577 6480464 Estradiol results in increased expression of TP53BP1 protein CTD PMID:31939680 1H-pyrazole increases expression ISO RGD:1317578 6480464 pyrazole results in increased expression of TRP53BP1 mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1317577 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317578 6480464 Tetrachlorodibenzodioxin affects the expression of TRP53BP1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TP53BP1 mRNA CTD PMID:33387578 2,4,6-tribromophenol decreases expression ISO RGD:1317577 6480464 2 more ... CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1317577 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TP53BP1 mRNA CTD PMID:28628672 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:1317577 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53BP1 protein CTD PMID:26231820 4-hydroxyphenyl retinamide increases expression ISO RGD:1317577 6480464 Fenretinide results in increased expression of TP53BP1 mRNA CTD PMID:16570282 5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid multiple interactions ISO RGD:1317577 6480464 pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid inhibits the reaction [Adenosine Triphosphate promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]] CTD PMID:32941855 acrolein multiple interactions ISO RGD:1317577 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TP53BP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TP53BP1 mRNA CTD PMID:32699268 adenosine multiple interactions ISO RGD:1317577 6480464 Adenosine promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 adenosine 5'-monophosphate multiple interactions ISO RGD:1317577 6480464 Adenosine Monophosphate promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 ADP multiple interactions ISO RGD:1317577 6480464 Adenosine Diphosphate promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] more ... CTD PMID:32941855 aflatoxin B1 increases expression ISO RGD:1317578 6480464 Aflatoxin B1 results in increased expression of TRP53BP1 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1317577 6480464 Aflatoxin B1 results in increased methylation of TP53BP1 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of TP53BP1 mRNA CTD PMID:24977338 alpha-pinene multiple interactions ISO RGD:1317577 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TP53BP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TP53BP1 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO RGD:1317577 6480464 aristolochic acid I results in decreased expression of TP53BP1 mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:1317577 6480464 Arsenic results in decreased expression of TP53BP1 mRNA CTD PMID:29161537 arsenic atom decreases expression ISO RGD:1317577 6480464 Arsenic results in decreased expression of TP53BP1 mRNA CTD PMID:29161537 ATP multiple interactions ISO RGD:1317577 6480464 Adenosine Triphosphate promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] more ... CTD PMID:32941855 atrazine increases expression ISO RGD:1317577 6480464 Atrazine results in increased expression of TP53BP1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1317578 6480464 Benzo(a)pyrene results in increased expression of TRP53BP1 mRNA, Benzo(a)pyrene results in increased expression of TRP53BP1 protein CTD PMID:22228805 , PMID:33393179 benzo[a]pyrene affects methylation ISO RGD:1317577 6480464 Benzo(a)pyrene affects the methylation of TP53BP1 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1317577 6480464 Benzo(a)pyrene results in increased methylation of TP53BP1 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1317578 6480464 pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TRP53BP1 protein] CTD PMID:33393179 benzo[a]pyrene multiple interactions ISO RGD:1317577 6480464 pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53BP1 protein] CTD PMID:33393179 benzo[a]pyrene increases expression ISO RGD:1317577 6480464 Benzo(a)pyrene results in increased expression of TP53BP1 protein CTD PMID:32717239 , PMID:33393179 biphenyl-4-amine multiple interactions ISO RGD:1317577 6480464 TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of TP53BP1 mRNA] CTD PMID:32905825 biphenyl-4-amine increases expression ISO RGD:1317577 6480464 4-biphenylamine results in increased expression of TP53BP1 mRNA CTD PMID:32905825 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:1317577 6480464 Mustard Gas results in increased phosphorylation of TP53BP1 protein CTD PMID:19845377 bisphenol A increases expression ISO RGD:1317577 6480464 bisphenol A results in increased expression of TP53BP1 mRNA, bisphenol A results in increased expression of TP53BP1 protein CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TP53BP1 mRNA CTD PMID:32528016 bisphenol A decreases expression ISO RGD:1317577 6480464 bisphenol A results in decreased expression of TP53BP1 protein CTD PMID:31675489 bisphenol A increases methylation ISO RGD:1317577 6480464 bisphenol A results in increased methylation of TP53BP1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TP53BP1 mRNA CTD PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TP53BP1 mRNA CTD PMID:30816183 bisphenol F multiple interactions ISO RGD:1317577 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TP53BP1 mRNA CTD PMID:28628672 bortezomib multiple interactions ISO RGD:1317577 6480464 TP53BP1 protein affects the reaction [[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased cleavage of PARP1 protein], TP53BP1 protein affects the reaction [[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased phosphorylation of RB1 protein] CTD PMID:25522274 brefeldin A increases expression ISO RGD:1317577 6480464 Brefeldin A results in increased expression of TP53BP1 protein CTD PMID:27358234 caffeine affects phosphorylation ISO RGD:1317577 6480464 Caffeine affects the phosphorylation of TP53BP1 protein CTD PMID:35688186 CGP 52608 multiple interactions ISO RGD:1317577 6480464 CGP 52608 promotes the reaction [RORA protein binds to TP53BP1 gene] CTD PMID:28238834 chromium(6+) decreases expression ISO RGD:1317577 6480464 chromium hexavalent ion results in decreased expression of TP53BP1 mRNA CTD PMID:27793765 cisplatin increases phosphorylation ISO RGD:1317578 6480464 Cisplatin results in increased phosphorylation of TRP53BP1 protein CTD PMID:22006019 cisplatin increases expression ISO RGD:1317577 6480464 Cisplatin results in increased expression of TP53BP1 protein CTD PMID:27358234 coumarin affects phosphorylation ISO RGD:1317577 6480464 coumarin affects the phosphorylation of TP53BP1 protein CTD PMID:35688186 crocidolite asbestos affects expression ISO RGD:1317577 6480464 Asbestos, Crocidolite affects the expression of TP53BP1 mRNA CTD PMID:17331233 crocidolite asbestos decreases expression ISO RGD:1317578 6480464 Asbestos, Crocidolite results in decreased expression of TRP53BP1 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO RGD:1317577 6480464 Cyclosporine results in increased expression of TP53BP1 mRNA CTD PMID:20106945 decabromodiphenyl ether increases expression ISO RGD:1317577 6480464 decabromobiphenyl ether results in increased expression of TP53BP1 protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:1317577 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TP53BP1 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO RGD:1317578 6480464 Dibutyl Phthalate results in decreased expression of TRP53BP1 mRNA CTD PMID:31318015 doxorubicin decreases expression ISO RGD:1317577 6480464 Doxorubicin results in decreased expression of TP53BP1 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:1317577 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TP53BP1 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:1317578 6480464 Ethanol affects the splicing of TRP53BP1 mRNA CTD PMID:30319688 etoposide multiple interactions ISO RGD:1317577 6480464 pifithrin inhibits the reaction [Etoposide results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:26259609 etoposide increases expression ISO RGD:1317577 6480464 Etoposide results in increased expression of TP53BP1 protein CTD PMID:26259609 , PMID:27358234 fenthion decreases expression ISO RGD:1317578 6480464 Fenthion results in decreased expression of TRP53BP1 mRNA CTD PMID:34813904 folic acid decreases expression ISO RGD:1317578 6480464 Folic Acid results in decreased expression of TRP53BP1 mRNA CTD PMID:25629700 GDP multiple interactions ISO RGD:1317577 6480464 Guanosine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 geldanamycin increases expression ISO RGD:1317577 6480464 geldanamycin results in increased expression of TP53BP1 mRNA CTD PMID:26705709 GTP multiple interactions ISO RGD:1317577 6480464 Guanosine Triphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 guanosine multiple interactions ISO RGD:1317577 6480464 Guanosine inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 hexadecanoic acid affects phosphorylation ISO RGD:1317577 6480464 Palmitic Acid affects the phosphorylation of TP53BP1 protein CTD PMID:28073184 hydrogen peroxide multiple interactions ISO RGD:1317578 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 IDP multiple interactions ISO RGD:1317577 6480464 Inosine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 indometacin multiple interactions ISO RGD:1317577 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TP53BP1 mRNA CTD PMID:28628672 inosine multiple interactions ISO RGD:1317577 6480464 Inosine inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 ivermectin decreases expression ISO RGD:1317577 6480464 Ivermectin results in decreased expression of TP53BP1 protein CTD PMID:32959892 mercury dichloride decreases expression ISO RGD:1317577 6480464 Mercuric Chloride results in decreased expression of TP53BP1 mRNA CTD PMID:27188386 methidathion decreases expression ISO RGD:1317578 6480464 methidathion results in decreased expression of TRP53BP1 mRNA CTD PMID:34813904 methylmercury chloride increases expression ISO RGD:1317577 6480464 methylmercuric chloride results in increased expression of TP53BP1 mRNA CTD PMID:28001369 N-methyl-N-nitrosourea increases expression ISO RGD:1317577 6480464 Methylnitrosourea results in increased expression of TP53BP1 protein CTD PMID:27233451 nitric oxide decreases expression ISO RGD:1317578 6480464 Nitric Oxide deficiency results in decreased expression of TRP53BP1 mRNA CTD PMID:15878706 oxaliplatin increases expression ISO RGD:1317577 6480464 oxaliplatin results in increased expression of TP53BP1 protein CTD PMID:21285347 oxaliplatin multiple interactions ISO RGD:1317577 6480464 MSH3 protein promotes the reaction [oxaliplatin results in increased expression of TP53BP1 protein] CTD PMID:21285347 oxybenzone increases expression ISO RGD:1317577 6480464 oxybenzone results in increased expression of TP53BP1 protein CTD PMID:31939680 ozone multiple interactions ISO RGD:1317577 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TP53BP1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1317578 6480464 Acetaminophen affects the expression of TRP53BP1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TP53BP1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1317578 6480464 Acetaminophen results in increased expression of TRP53BP1 protein CTD PMID:29540258 pentachlorophenol increases expression ISO RGD:1317578 6480464 Pentachlorophenol results in increased expression of TRP53BP1 mRNA CTD PMID:23892564 phenobarbital affects expression ISO RGD:1317578 6480464 Phenobarbital affects the expression of TRP53BP1 mRNA CTD PMID:23091169 pinocembrin multiple interactions ISO RGD:1317577 6480464 pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53BP1 protein] CTD PMID:33393179 pinocembrin multiple interactions ISO RGD:1317578 6480464 pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TRP53BP1 protein] CTD PMID:33393179 potassium chromate decreases expression ISO RGD:1317577 6480464 potassium chromate(VI) results in decreased expression of TP53BP1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1317577 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TP53BP1 mRNA CTD PMID:22079256 propylparaben increases expression ISO RGD:1317577 6480464 propylparaben results in increased expression of TP53BP1 protein CTD PMID:31939680 quercetin increases phosphorylation ISO RGD:1317577 6480464 Quercetin results in increased phosphorylation of TP53BP1 protein CTD PMID:35688186 rac-1,2-dichloropropane affects localization ISO RGD:1317577 6480464 propylene dichloride affects the localization of TP53BP1 protein CTD PMID:28300663 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of TP53BP1 mRNA CTD PMID:33775663 sodium arsenate increases expression ISO RGD:1317578 6480464 sodium arsenate results in increased expression of TRP53BP1 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1317577 6480464 sodium arsenite results in decreased expression of TP53BP1 mRNA CTD PMID:29161537 sodium arsenite increases activity ISO RGD:1317577 6480464 sodium arsenite results in increased activity of TP53BP1 protein CTD PMID:30528433 sodium arsenite multiple interactions ISO RGD:1317577 6480464 sodium arsenite promotes the reaction [TP53BP1 protein binds to Ribonucleotides] CTD PMID:30528433 tamoxifen affects expression ISO RGD:1317578 6480464 Tamoxifen affects the expression of TRP53BP1 mRNA CTD PMID:20937368 tert-butyl hydroperoxide decreases expression ISO RGD:1317577 6480464 tert-Butylhydroperoxide results in decreased expression of TP53BP1 mRNA CTD PMID:27509014 tert-butyl hydroperoxide decreases methylation ISO RGD:1317577 6480464 tert-Butylhydroperoxide results in decreased methylation of TP53BP1 gene CTD PMID:27509014 thimerosal decreases expression ISO RGD:1317577 6480464 Thimerosal results in decreased expression of TP53BP1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TP53BP1 mRNA CTD PMID:23411599 torcetrapib increases expression ISO RGD:1317577 6480464 torcetrapib results in increased expression of TP53BP1 mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1317577 6480464 trichostatin A results in decreased expression of TP53BP1 mRNA CTD PMID:24935251 triptonide decreases expression ISO RGD:1317578 6480464 triptonide results in decreased expression of TRP53BP1 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1317578 6480464 Tungsten results in decreased expression of TRP53BP1 mRNA CTD PMID:30912803 UDP multiple interactions ISO RGD:1317577 6480464 Uridine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 UTP multiple interactions ISO RGD:1317577 6480464 Uridine Triphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein] CTD PMID:32941855 valproic acid decreases expression ISO RGD:1317577 6480464 Valproic Acid results in decreased expression of TP53BP1 mRNA CTD PMID:24935251 vorinostat decreases expression ISO RGD:1317577 6480464 vorinostat results in decreased expression of TP53BP1 mRNA CTD PMID:27188386
